366 related articles for article (PubMed ID: 33402095)
1. Microbiology of secondary infections in Buruli ulcer lesions; implications for therapeutic interventions.
Gyamfi E; Narh CA; Quaye C; Abbass A; Dzudzor B; Mosi L
BMC Microbiol; 2021 Jan; 21(1):4. PubMed ID: 33402095
[TBL] [Abstract][Full Text] [Related]
2. Secondary bacterial infections of buruli ulcer lesions before and after chemotherapy with streptomycin and rifampicin.
Yeboah-Manu D; Kpeli GS; Ruf MT; Asan-Ampah K; Quenin-Fosu K; Owusu-Mireku E; Paintsil A; Lamptey I; Anku B; Kwakye-Maclean C; Newman M; Pluschke G
PLoS Negl Trop Dis; 2013; 7(5):e2191. PubMed ID: 23658847
[TBL] [Abstract][Full Text] [Related]
3. Mycobacterium ulcerans-Bordetella trematum chronic tropical cutaneous ulcer: A four-case series, Côte d'Ivoire.
Tchan BGO; Kakou-Ngazoa S; Dizoe S; Hammoudi N; Grine G; Ruimy R; Drancourt M
PLoS Negl Trop Dis; 2023 Dec; 17(12):e0011413. PubMed ID: 38060465
[TBL] [Abstract][Full Text] [Related]
4. Clearance of viable Mycobacterium ulcerans from Buruli ulcer lesions during antibiotic treatment as determined by combined 16S rRNA reverse transcriptase /IS 2404 qPCR assay.
Sarpong-Duah M; Frimpong M; Beissner M; Saar M; Laing K; Sarpong F; Loglo AD; Abass KM; Frempong M; Sarfo FS; Bretzel G; Wansbrough-Jones M; Phillips RO
PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005695. PubMed ID: 28671942
[TBL] [Abstract][Full Text] [Related]
5. Genetic diversity of Staphylococcus aureus in Buruli ulcer.
Amissah NA; Glasner C; Ablordey A; Tetteh CS; Kotey NK; Prah I; van der Werf TS; Rossen JW; van Dijl JM; Stienstra Y
PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003421. PubMed ID: 25658641
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes of Ghanaian Buruli ulcer patients who defaulted from antimicrobial therapy.
Klis S; Kingma RA; Tuah W; van der Werf TS; Stienstra Y
Trop Med Int Health; 2016 Sep; 21(9):1191-6. PubMed ID: 27456068
[TBL] [Abstract][Full Text] [Related]
7.
Kwofie SK; Dankwa B; Odame EA; Agamah FE; Doe LPA; Teye J; Agyapong O; Miller WA; Mosi L; Wilson MD
Molecules; 2018 Jun; 23(7):. PubMed ID: 29954088
[TBL] [Abstract][Full Text] [Related]
8. Towards rational use of antibiotics for suspected secondary infections in Buruli ulcer patients.
Barogui YT; Klis S; Bankolé HS; Sopoh GE; Mamo S; Baba-Moussa L; Manson WL; Johnson RC; van der Werf TS; Stienstra Y
PLoS Negl Trop Dis; 2013; 7(1):e2010. PubMed ID: 23359827
[TBL] [Abstract][Full Text] [Related]
9. Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial.
Phillips RO; Robert J; Abass KM; Thompson W; Sarfo FS; Wilson T; Sarpong G; Gateau T; Chauty A; Omollo R; Ochieng Otieno M; Egondi TW; Ampadu EO; Agossadou D; Marion E; Ganlonon L; Wansbrough-Jones M; Grosset J; Macdonald JM; Treadwell T; Saunderson P; Paintsil A; Lehman L; Frimpong M; Sarpong NF; Saizonou R; Tiendrebeogo A; Ohene SA; Stienstra Y; Asiedu KB; van der Werf TS;
Lancet; 2020 Apr; 395(10232):1259-1267. PubMed ID: 32171422
[TBL] [Abstract][Full Text] [Related]
10. Co-infection of HIV in patients with Buruli ulcer disease in Central Ghana.
Amoako YA; Loglo AD; Frimpong M; Agbavor B; Abass MK; Amofa G; Ofori E; Ampadu E; Asiedu K; Stienstra Y; Wansbrough-Jones M; van der Werf T; Phillips RO
BMC Infect Dis; 2021 Apr; 21(1):331. PubMed ID: 33832460
[TBL] [Abstract][Full Text] [Related]
11. Variable Number Tandem Repeat Profiling of
Gyamfi E; Dogbe MA; Quaye C; Affouda AA; Kyei-Baffour E; Awuku-Asante D; Sarpong-Duah M; Mosi L
Front Microbiol; 2022; 13():872579. PubMed ID: 35814673
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomised controlled trial.
Nienhuis WA; Stienstra Y; Thompson WA; Awuah PC; Abass KM; Tuah W; Awua-Boateng NY; Ampadu EO; Siegmund V; Schouten JP; Adjei O; Bretzel G; van der Werf TS
Lancet; 2010 Feb; 375(9715):664-72. PubMed ID: 20137805
[TBL] [Abstract][Full Text] [Related]
13. Ethnopharmacological reports on anti-Buruli ulcer medicinal plants in three West African countries.
Tsouh Fokou PV; Nyarko AK; Appiah-Opong R; Tchokouaha Yamthe LR; Addo P; Asante IK; Boyom FF
J Ethnopharmacol; 2015 Aug; 172():297-311. PubMed ID: 26099634
[TBL] [Abstract][Full Text] [Related]
14. [Paradoxical reactions and responses during antibiotic treatment for Mycobacterium ulcerans infection (Buruli ulcer). Four cases from French Guiana].
Sambourg E; Dufour J; Edouard S; Morris A; Mosnier E; Reynaud Y; Sainte-Marie D; Nacher M; Guégan JF; Couppié P
Ann Dermatol Venereol; 2014; 141(6-7):413-8. PubMed ID: 24951139
[TBL] [Abstract][Full Text] [Related]
15. Response to treatment in a prospective cohort of patients with large ulcerated lesions suspected to be Buruli Ulcer (Mycobacterium ulcerans disease).
Kibadi K; Boelaert M; Fraga AG; Kayinua M; Longatto-Filho A; Minuku JB; Mputu-Yamba JB; Muyembe-Tamfum JJ; Pedrosa J; Roux JJ; Meyers WM; Portaels F
PLoS Negl Trop Dis; 2010 Jul; 4(7):e736. PubMed ID: 20625556
[TBL] [Abstract][Full Text] [Related]
16. Shortening Buruli Ulcer Treatment with Combination Therapy Targeting the Respiratory Chain and Exploiting Mycobacterium ulcerans Gene Decay.
Converse PJ; Almeida DV; Tyagi S; Xu J; Nuermberger EL
Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31036687
[TBL] [Abstract][Full Text] [Related]
17. Secondary bacterial isolates from previously untreated Buruli ulcer lesions and their antibiotic susceptibility patterns in Southern Nigeria.
Anyim MC; Meka AO; Chukwu JN; Nwafor CC; Oshi DC; Madichie NO; Ekeke N; Alphonsus C; Mbah O; Nwaekpe C; Njoku M; Fakiyesi D; Ulodiaku V; Ejiofor I; Bisiriyu AH; Ukwaja KN
Rev Soc Bras Med Trop; 2016; 49(6):746-751. PubMed ID: 28001222
[TBL] [Abstract][Full Text] [Related]
18. Case Report: A New Mycobacterium ulcerans Genotype Causing Buruli Ulcer in Côte d'Ivoire.
Bahadoran P; Hammoudi N; Gaudart A; Saad J; Di Filippo Y; Drancourt M; Ruimy R
Am J Trop Med Hyg; 2021 Apr; 104(5):1782-1783. PubMed ID: 33819173
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic management of
Van Der Werf TS; Barogui YT; Converse PJ; Phillips RO; Stienstra Y
Expert Rev Clin Pharmacol; 2020 Apr; 13(4):391-401. PubMed ID: 32310683
[TBL] [Abstract][Full Text] [Related]
20.
Tchan BGO; Ngazoa-Kakou S; Aka N; Apia NKB; Hammoudi N; Drancourt M; Saad J
Microbiol Spectr; 2023 Jun; 11(3):e0034223. PubMed ID: 37222600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
